PSMC3IP as a prognostic biomarker and immunomodulatory regulator in low-grade glioma: insights from multi-omics and methylation analysis
PSMC3IP is overexpressed in LGG and serves as an independent prognostic factor for poor survival. Its involvement in immune regulation and key molecular pathways, including DNA replication, suggests it may be a target for therapeutic strategies in LGG.
Authors
- Yanzheng Gao (ORCID: https://orcid.org/0000-0002-2937-815X)
- Yusheng Chen
- Sujie Gu
- Hao Wang (ORCID: https://orcid.org/0000-0003-4909-8937)
- Zongye Zhang
- Zhendong Liu (ORCID: https://orcid.org/0000-0002-8339-4054)
- Xingbo Cheng (ORCID: https://orcid.org/0000-0003-3178-4138)
- Zhou Sha
Institutions
- Zhengzhou University (CN)
- Zhengzhou People's Hospital (CN)
Publication Details
- Journal
- Neurological Research
- Published
- 2025-07-20
- DOI
- https://doi.org/10.1080/01616412.2025.2528159
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00